Literature DB >> 22318094

Bone loss associated with prevention of breast cancer.

Jane A Cauley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22318094     DOI： 10.1016/S1470-2045(12)70030-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Longitudinal changes of trabecular bone score after estrogen deprivation: effect of menopause and aromatase inhibition.

Authors:  M Pedrazzoni; A Casola; I Verzicco; B Abbate; R Vescovini; P Sansoni
Journal:  J Endocrinol Invest       Date:  2014-07-19       Impact factor: 4.256

2.  Aromatase inhibitors-induced bone loss in early breast cancer.

Authors:  Jean-Jacques Body
Journal:  Bonekey Rep       Date:  2012-10-03

Review 3.  Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis.

Authors:  Irit Ben-Aharon; Liat Vidal; Shulamith Rizel; Rinat Yerushalmi; Ofer Shpilberg; Aaron Sulkes; Salomon M Stemmer
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

4.  Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study.

Authors:  Namki Hong; Seung Won Burm; Graham Treece; Jee Ye Kim; Min Hwan Kim; Seunghyun Lee; Sungjae Shin; Yumie Rhee
Journal:  J Bone Oncol       Date:  2021-12-29       Impact factor: 4.072
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.